POSTER: ABCL-544 Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): 2 Year Follow-Up of the Phase 3 STARGLO Trial

Jeremy S. Abramson; Matthew Ku; Mark Hertzberg; Christopher P. Fox; Charles Herbaux; Hui-Qiang Huang; Dok Hyun Yoon; Won Seog Kim; Huilai Zhang; Haifaa Abdulhaq; William Townsend; Estefania Mulvihill; Victor Orellana-Noia; Richard Ta; Huang Huang; Martine Joanna Kallemeijn; Anton Belousov; Alessia Bottos; Linda Lundberg; Gareth P. Gregory

doi:10.1016/S2152-2650(25)01007-9

$POSTER: ABCL-544 Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): 2 Year Follow-Up of the Phase 3 STARGLO Trial$

Article de revue

Avec comité de lecture

POSTER: ABCL-544 Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): 2 Year Follow-Up of the Phase 3 STARGLO Trial

Jeremy S. Abramson, Matthew Ku, Mark Hertzberg, Christopher P. Fox, Charles Herbaux, Hui-Qiang Huang, Dok Hyun Yoon, Won Seog Kim, Huilai Zhang, Haifaa Abdulhaq, …

Clinical lymphoma, myeloma and leukemia, Vol.25, pp.S257-S257

09/2025

DOI: https://doi.org/10.1016/S2152-2650(25)01007-9

Indicateurs

1 Consultations de la notice

Détails

Titre: POSTER: ABCL-544 Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): 2 Year Follow-Up of the Phase 3 STARGLO Trial
Créateurs - sans rôle: Jeremy S. Abramson - Massachusetts General Hospital
Matthew Ku - The University of Melbourne
Mark Hertzberg - UNSW Sydney
Christopher P. Fox - University of Nottingham
Charles Herbaux - University Hospital of Montpellier, Montpellier, France
Hui-Qiang Huang - Sun Yat-sen University Cancer Center, Guangzhou, China
Dok Hyun Yoon - University of Ulsan
Won Seog Kim - Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
Huilai Zhang - Tianjin Medical University
Haifaa Abdulhaq - University of California, San Francisco
William Townsend - University College London Hospitals, London, United Kingdom
Estefania Mulvihill - F. Hoffmann-La Roche Ltd, Basel, Switzerland
Victor Orellana-Noia - Genentech
Richard Ta - Genentech
Huang Huang - F. Hoffmann-La Roche Ltd, Mississauga, ON, Canada
Martine Joanna Kallemeijn - F. Hoffmann-La Roche Ltd, Basel, Switzerland
Anton Belousov - F. Hoffmann-La Roche Ltd, Basel, Switzerland
Alessia Bottos - F. Hoffmann-La Roche Ltd, Basel, Switzerland
Linda Lundberg - F. Hoffmann-La Roche Ltd, Basel, Switzerland
Gareth P. Gregory - Monash University
Détails de publication: Clinical lymphoma, myeloma and leukemia, Vol.25, pp.S257-S257
Éditeur: Elsevier Inc
Identifiants: 99139756009311
Unité académique: Institut de Génétique Humaine - IGH
Langue: English
Type de ressource: Journal article